Mylan said it has agreed to buy Swedish pharmaceutical company Meda for $7.2 billion in cash and stock, while the drug maker also reported slower-than-expected growth in its fourth quarter.
from WSJ.com: US Business http://ift.tt/1QWr4tR
via IFTTT
No comments:
Post a Comment